13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001104659-26-015410
Total Value
$164.4M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ALUMIS INC. | ALMS | 5,779,348 | $56.4M | 34.31% |
| 2 | CG Oncology, Inc. | CGON | 1,004,050 | $41.7M | 25.36% |
| 3 | Disc Medicine, Inc. | IRON | 299,069 | $23.7M | 14.45% |
| 4 | Natera, Inc. | NTRA | 67,356 | $15.4M | 9.39% |
| 5 | Lyell Immunopharma, Inc. | LYEL | 477,078 | $14.7M | 8.93% |
| 6 | Hims & Hers Health, Inc. | HIMS | 273,151 | $8.9M | 5.39% |
| 7 | Maze Therapeutics, Inc. | MAZE | 86,291 | $3.6M | 2.17% |